Bioelectricity, New Peer Reviewed Journal Announced
An Outstanding and Influential Foundation for a Dynamic, Emerging Field
Toward a Universal Flu Vaccine
New Candidate Fights Back against the Flu’s Efforts to Undermine the Human Immune System
Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
Seeking New Users for iSeq
The Changing Sequencing Landscape
For full access to this article login to GEN Select now.
Targeting Progenitor Cells to Regenerate Damaged Tissue
Progenitor Cells Studies May Show the Path toward Curing Chronic Diseases
- The promise of cell therapy for regenerative medicine is often viewed as being synonymous with stem cell therapy, but some companies are instead successfully bringing progenitor cell-based cell therapy approaches through preclinical and clinical development. They are targeting disorders that include type 1 diabetes, hearing loss, Duchenne muscular dystrophy ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.